Get the Stockscreener App
0.00
100.00%
-7.539
Kintara Therapeutics Inc Stock (KTRA) Forecast
The Kintara Therapeutics Inc (KTRA) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $31.94, representing a + increase from the current price of $0.00. The highest analyst price target is $49.31, and the lowest is $14.57.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month KTRA Price Target
Average 49.13
(+ Upside)
Is Kintara Therapeutics Inc (KTRA) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 22.96 | Buy |
| STOCH(9,6) | 49.21 | Neutral |
| STOCHRSI(14) | 66.09 | Neutral |
| MACD(12,26) | -0.3399 | Sell |
| ADX(14) | 22.38 | Neutral |
| William %R | -100.00 | Buy |
| CCI(14) | -493.41 | Sell |
Buy: 2
Sell: 2
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
6.2867
Sell
|
5.8383
Sell
|
| MA20 |
6.3936
Sell
|
6.2181
Sell
|
| MA50 |
6.5375
Sell
|
6.5924
Sell
|
| MA100 |
7.5568
Sell
|
8.1026
Sell
|
| MA200 |
5.9643
Sell
|
20.33
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, KTRA could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 12 signaling Sell signals and 3 Neutral signals. This might not be a good time to consider opening new positions on KTRA, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 22.96 indicates that KTRA is oversold. This indicates that KTRA price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 49.21 indicates that KTRA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 66.09 indicates that KTRA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 22.38 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -493.41 indicates that KTRA is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term KTRA price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Kintara Therapeutics Inc financial reports and earnings history, Kintara Therapeutics Inc (KTRA) stock could reach $46.41 by 2030, $59.06 by 2040 and $230.75 by 2050. See the projected annual prices until 2050 of the Kintara Therapeutics Inc stock below:
- Kintara Therapeutics Inc (KTRA) is expected to reach an average price of $69.45 in 2035, with a high prediction of $71.31 and a low estimate of $69.72. This indicates an $ rise from the last recorded price of $0.00.
- Kintara Therapeutics Inc (KTRA) stock is projected to chart a bullish course in 2040, with an average price target of $55.63, representing an $ surge from its current level. The forecast ranges from a conservative $56.10 to a sky-high $59.06.
- Our analysts predict Kintara Therapeutics Inc (KTRA) to jump by 2045, soaring from $18.93 to an average price of $18.92, potentially reaching $22.77. While $18.93 is the low estimate, the potential upside is significant.
- Kintara Therapeutics Inc (KTRA) stock is expected to climb by 2050, reaching an average of $234.77, a $ jump from its current level. However, a wide range of estimates exists, with high and low targets of $230.75 and $238.77, respectively, highlighting the market's uncertainty.
Kintara Therapeutics Inc Stock (KTRA) Year by Year Forecast
Kintara Therapeutics Inc Stock (KTRA) Price Forecast for 2025
Kintara Therapeutics Inc Stock (KTRA) is expected to reach an average price of $49.13 in 2025, with a high prediction of $97.95 and a low estimate of $0.3039. This indicates an + rise from the last recorded price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $28.57 | $14.57 | $49.31 | + |
| February, 2025 | $30.12 | $15.36 | $33.34 | + |
| March, 2025 | $52.16 | $26.88 | $65.38 | + |
| April, 2025 | $35.97 | $33.47 | $97.95 | + |
| May, 2025 | $34.51 | $29.75 | $40.23 | + |
| June, 2025 | $34.56 | $28.08 | $37.56 | + |
| July, 2025 | $0.7653 | $0.6653 | $35.34 | + |
| August, 2025 | $3.4101 | $0.3039 | $15.15 | + |
| September, 2025 | $0.8901 | $1.3063 | $13.17 | + |
| October, 2025 | $7.499 | $3.7839 | $5.239 | + |
| November, 2025 | $16.44 | $11.47 | $12.64 | + |
| December, 2025 | $14.45 | $14.15 | $14.43 | + |
Kintara Therapeutics Inc Stock (KTRA) Price Forecast for 2026
The predicted value for Kintara Therapeutics Inc (KTRA) in 2026 is set at an average of $17.49. Estimates vary from a peak of $21.43 to a trough of $13.55, indicating an + surge from the present price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $17.34 | $16.25 | $15.64 | + |
| February, 2026 | $13.30 | $13.75 | $14.58 | + |
| March, 2026 | $17.25 | $14.51 | $16.52 | + |
| April, 2026 | $21.45 | $21.99 | $21.43 | + |
| May, 2026 | $15.15 | $19.03 | $20.84 | + |
| June, 2026 | $16.06 | $16.38 | $15.45 | + |
| July, 2026 | $18.72 | $18.10 | $17.05 | + |
| August, 2026 | $17.58 | $18.96 | $18.43 | + |
| September, 2026 | $19.94 | $18.40 | $18.87 | + |
| October, 2026 | $18.34 | $18.63 | $18.23 | + |
| November, 2026 | $15.91 | $18.55 | $18.50 | + |
| December, 2026 | $14.42 | $13.55 | $12.84 | + |
Kintara Therapeutics Inc Stock (KTRA) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Kintara Therapeutics Inc (KTRA) is $9.2904, with a high forecast of $13.64 and a low forecast of $4.9375. This indicates an + increase from the last price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $13.70 | $13.74 | $12.92 | + |
| February, 2027 | $13.34 | $13.32 | $13.26 | + |
| March, 2027 | $14.06 | $13.82 | $13.64 | + |
| April, 2027 | $14.03 | $13.88 | $13.61 | + |
| May, 2027 | $12.76 | $12.82 | $13.02 | + |
| June, 2027 | $11.13 | $11.51 | $12.38 | + |
| July, 2027 | $8.4692 | $9.7491 | $10.42 | + |
| August, 2027 | $7.9744 | $8.1032 | $8.1469 | + |
| September, 2027 | $6.5683 | $7.1383 | $7.896 | + |
| October, 2027 | $5.7135 | $6.3659 | $6.0471 | + |
| November, 2027 | $5.0187 | $5.6987 | $5.4699 | + |
| December, 2027 | $7.3567 | $4.9375 | $7.496 | + |
Kintara Therapeutics Inc Stock (KTRA) Price Forecast for 2028
In 2028, Kintara Therapeutics Inc (KTRA) is projected to reach an average price of $26.73, with a high projection of $53.20 and a low estimate of $0.2638. This indicates an + rise from the last price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $6.4644 | $6.4678 | $7.071 | + |
| February, 2028 | $5.4763 | $5.496 | $6.2048 | + |
| March, 2028 | $4.202 | $4.2049 | $5.2204 | + |
| April, 2028 | $3.1751 | $3.1915 | $3.9354 | + |
| May, 2028 | $1.8721 | $1.8901 | $2.9149 | + |
| June, 2028 | $0.7824 | $0.8202 | $1.4749 | + |
| July, 2028 | $54.18 | $0.2638 | $53.20 | + |
| August, 2028 | $41.57 | $40.61 | $47.66 | + |
| September, 2028 | $33.98 | $34.02 | $29.48 | + |
| October, 2028 | $34.89 | $37.28 | $40.94 | + |
| November, 2028 | $38.28 | $38.80 | $34.67 | + |
| December, 2028 | $27.69 | $35.69 | $33.76 | + |
Kintara Therapeutics Inc Stock (KTRA) Price Forecast for 2029
The 2029 price forecast for Kintara Therapeutics Inc Stock (KTRA) is $34.50 on average, with a high prediction of $66.90 and a low estimate of $2.0988. This represents an + increase from the previous price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $15.42 | $2.0988 | $66.90 | + |
| February, 2029 | $4.0133 | $3.0133 | $26.95 | + |
| March, 2029 | $2.8971 | $7.9195 | $11.54 | + |
| April, 2029 | $27.31 | $26.37 | $22.67 | + |
| May, 2029 | $1.6954 | $11.20 | $23.79 | + |
| June, 2029 | $7.3943 | $3.3495 | $53.39 | + |
| July, 2029 | $10.02 | $2.5833 | $14.91 | + |
| August, 2029 | $8.404 | $10.47 | $7.9488 | + |
| September, 2029 | $38.31 | $10.36 | $6.8367 | + |
| October, 2029 | $34.20 | $39.55 | $37.75 | + |
| November, 2029 | $38.72 | $33.88 | $32.61 | + |
| December, 2029 | $42.53 | $41.34 | $40.05 | + |
Kintara Therapeutics Inc Stock (KTRA) Price Forecast for 2030
Kintara Therapeutics Inc Stock (KTRA) is expected to reach an average price of $48.00 in 2030, with a high forecast of $52.40 and a low forecast of $43.60. This signifies an + surge from the last price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $48.96 | $45.22 | $46.41 | + |
| February, 2030 | $48.08 | $50.59 | $50.37 | + |
| March, 2030 | $50.48 | $49.30 | $50.01 | + |
| April, 2030 | $47.37 | $50.04 | $48.94 | + |
| May, 2030 | $49.90 | $46.55 | $48.53 | + |
| June, 2030 | $54.13 | $50.51 | $52.40 | + |
| July, 2030 | $49.33 | $50.01 | $51.42 | + |
| August, 2030 | $44.73 | $45.26 | $44.07 | + |
| September, 2030 | $44.75 | $45.32 | $44.65 | + |
| October, 2030 | $44.84 | $45.28 | $44.83 | + |
| November, 2030 | $45.05 | $44.14 | $43.41 | + |
| December, 2030 | $42.82 | $43.60 | $43.57 | + |
0.10%
0.76%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):